Does cancer start in the womb? Altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors

Journal of Mammary Gland Biology and Neoplasia

Volumn 18, Issue 2, 2013, Pages 199-208

  Soto, Ana M ^a   Brisken, Cathrin ^b   Schaeberle, Cheryl ^a   Sonnenschein, Carlos ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EPFL   (Switzerland)

Author keywords

Beaded duct; Ecological developmental biology; Neoplasia; Progesterone receptor; Tissue organization field theory; Xenoestrogen

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ADIPONECTIN; AMPHIREGULIN; CARCINOGEN; CHLORPHENOTANE; DESMIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MUTAGENIC AGENT; OSTEONECTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASTIC; PROGESTERONE RECEPTOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; VIMENTIN;

ADIPOGENESIS; ADULTHOOD; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST EPITHELIUM; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CONTAINER; DISEASE PREDISPOSITION; DROSOPHILA; EMBRYO DEVELOPMENT; EXPOSURE; EXTRACELLULAR MATRIX; FETUS DEVELOPMENT; FOOD PACKAGING; GENE EXPRESSION; GENOTYPE; GONADOTROPIN RELEASE; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; HYPERPLASIA; MALE GENITAL SYSTEM; MAMMARY GLAND; MOLECULAR BIOLOGY; MORPHOGENESIS; NONHUMAN; ORGANOGENESIS; OVARY CYCLE; PHENOTYPE; PRENATAL DEVELOPMENT; PROTEIN EXPRESSION; PUBERTY; REVIEW; RNA SPLICING; STROMA; UTERUS MYOMA; XENOPUS;

ANIMALS; BREAST NEOPLASMS; CARCINOGENESIS; ENDOCRINE DISRUPTORS; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL;

EID: 84879783158     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-013-9293-5     Document Type: Review

References (76)

1. Sallout B, Walker M. The fetal origin of adult diseases. J Obstet Gynaecol. 2003;23:555-60.
2. Barker DJP, Hanson MA. Altered regional blood flow in the fetus: the origins of cardiovascular disease? Acta Paediatricia. 2004;93:1559-60.
3. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm count and disorders of the male reproductive tract? Lancet. 1993;341:1392-5.
4. Skakkebaek NE, Meyts ER, Jorgensen N, et al. Germ cell cancer and disorders of spermatogenesis: an environmental connection? APMIS. 1998;106:3-12.
5. Markey CM, Rubin BS, Soto AM, Sonnenschein C. Endocrine disruptors from Wingspread to environmental developmental biology. J Steroid Biochem Mol Biol. 2003;83:235-44.
6. Trichopoulos D. Is breast cancer initiated in utero? Epidemiology. 1990;1:95-6.
7. Braun MM, Ahlbom A, Floderus B, Brinton LA, Hoover RN. Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). CCC. 1995;6:519-24.
8. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk. Lancet. 1992;340:1015-8.
9. Potischman N, Troisi R. In-utero and early life exposures in relation to risk of breast cancer. CCC. 1999;10:561-73.
10. Tamimi R, Lagiou P, Vatten LJ, et al. Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring. Cancer Epidemiol Biomarkers Prev. 2003;12:647-50.
11. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. New Engl J Med. 1971;284:878-81.
12. Mittendorf R. Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero. Teratology. 1995;51:435-45.
13. Palmer JR, Hatch EE, Rosenberg CL, et al. Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). CCC. 2002;13:753-8.
14. Boylan ES, Calhoon RE. Transplacental action of diethylstilbestrol on mammary carcinogenesis in female rats given one or two doses of 7,12-dimethylbenz(a)anthracene. Cancer Res. 1983;43:4879-84.
15. Rayner JL, Enoch RR, Fenton SE. Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth. Toxicol Sci. 2005;87:255-66.
16. White SS, Calafat AM, Kuklenyik Z, et al. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci. 2007;96:133-44.
17. Fenton SE, Hamm JT, Birnbaum L, Youngblood GL. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci. 2002;67:63-74.
18. Tomooka Y, Bern HA. Growth of mouse mammary glands after neonatal sex hormone treatment. J Nat Cancer Inst. 1982;69:1347-52.
19. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev. 2009;30:75-95.
20. Zoeller RT, Brown TR, Doan L, et al. Endocrine-dsrupting chemicals and public health protection: a statement of principles from the endocrine society. Endocrinology. 2012;153:4097-110.
21. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. Persistent DDT metabolite p, p'-DDE is a potent androgen receptor antagonist. Nature. 1995;375:581-5.
22. Moriyama K, Tagami T, Akamizu T, et al. Thyroid hormone action is disrupted by Bisphenol A as an antagonist. J Clin Endocrinol Metab. 2002;87:5185-90.
23. Zoeller RT, Bansal R, Parris C. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology. 2005;146:607-12.
24. Silva E, Rajapakse N, Kortenkamp A. Something from "nothing" - eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ Sci Technol. 2002;36:1751-6.
25. Nagel SC, vom Saal FS, Thayer KA, Dhar MG, Boechler M, Welshons WV. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect. 1997;105:70-6.
26. Watson CS, Bulayeva NN, Wozniak AL, Alyea RA. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids. 2007;72:124-34.
27. Soriano S, Alonso-Magdalena P, Garcia-Arevalo M, et al. Rapid insulinotropic action of low doses of Bisphenol-A on mouse and human Islets of Langerhans: Role of estrogen receptor beta. PLoS One. 2012;7:e31109.
28. Colborn T, Clement C. Chemically induced alterations in sexual and functional development: the wildlife/human connection. Princeton: Princeton Scientific Publishing. 1992.
29. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect. 1993;101:372-7.
30. Keri RA, Ho S-M, Hunt PA, Knudsen KE, Soto AM, Prins GS. An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol. 2007;24:240-52.
31. Soto AM, Sonnenschein C. Environmental causes of cancer: endocrine disruptors as carcinogens. Nat Rev Endocrinol. 2010;6:363-70.
32. Jacob F. The possible and the actual. Seattle, WA: University of Washington Press. 1982.
33. Longo G, Miquel P-A, Sonnenschein C, Soto AM. Is information a proper observable for biological organization? Prog Biophys Mol Biol. 2012;109:108-14.
34. Gilbert SF, Epel D. Ecological developmental biology: integrating epigenetics, medicine, and evolution. Sunderland MA: Sinauer Associates. 2009.
35. Weinberg RA. One renegade cell: How cancer begins. New York: Basic Books. 1998.
36. Vaux DL. In defense of the somatic mutation theory of cancer. BioEssays. 2011;33:341-3.
37. Ho S-M, Tang WY, de Frausto Belmonte J, Prins GS. Developmental exposure to estradiol and bisphenol a increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 2006;66:5624-32.
38. Soto AM, Sonnenschein C. The somatic mutation theory of cancer: growing problems with the paradigm? BioEssays. 2004;26:1097-107.
39. Sonnenschein C, Soto AM. The society of cells: Cancer and control of cell proliferation. New York: Springer Verlag. 1999.
40. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci. 2004;117:1495-502.
41. Maffini MV, Calabro JM, Soto AM, Sonnenschein C. Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma. Am J Pathol. 2005;167:1405-10.
42. Booth BW, Boulanger CA, Anderson LH, Smith GH. The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells. Oncogene. 2011;30:679-89.
43. Dodds EC, Lawson W. Synthetic estrogenic agents without the phenanthrene nucleus. Nature. 1936;137:996.
44. Dodds EC, Goldberg L, Lawson W, Robinson R. Estrogenic activity of certain synthetic compounds. Nature. 1938;141:247-8.
45. Burridge E. Chemical profile: bisphenol A. ICIS Chem Bus. 2008;274:48.
46. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007;24:139-77.
47. Vandenberg LN, Chauhoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating and tissue biomonitoring studies indicate widespread exposure to Bisphenol A. Environ Health Perspect. 2010;118:1055-70.
48. Taylor JA, vom Saal FS, Welshons WV et al. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ Health Perspect. 2011;119:422-30.
49. Veltmaat JM, Mailleux AA, Thiery JP, Bellusci S. Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation. Differentiation. 2003;71:1-17.
50. Cowin P, Wysolmerski J. Molecular mechanisms guiding embryonic mammary gland development. Cold Spring Harb Perspect Biol. 2010;2:a003251.
51. Vandenberg LN, Maffini MV, Wadia PR, Sonnenschein C, Rubin BS, Soto AM. Bisphenol A exposure alters fetal mammary gland development. Endocrinol Soc Meet. 2006;P1-177:205.
52. Wadia PR, Cabaton NJ, Borrero MD, Rubin BS, Sonnenschein C, Shioda T et al. Low-dose BPA exposure alters the mesenchymal and epithelial transcriptomes of the mouse fetal mammary gland. PLoS One. 2013. In Press.
53. Narbaitz R, Stumpf WE, Sar M. Estrogen receptors in the mammary gland primordia of fetal mouse. Anat Embryol. 1980;158:161-6.
54. Lemmen JG, Broekhof JLM, Kuiper GGJM, Gustafsson JA, Van Der Saag PT, van der Burg B. Expression of estrogen receptor alpha and beta during mouse embryogenesis. Mech Dev. 1999;81:163-7.
55. Vandenberg LN, Maffini MV, Wadia PR, Sonnenschein C, Rubin BS, Soto AM. Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology. 2007;148:116-27.
56. Zoeller RT. Environmental chemicals impacting the thyroid: targets and consequences. Thyroid. 2007;17:811-7.
57. de Toro Munoz MM, Markey CM, Wadia PR, et al. Perinatal exposure to Bisphenol A alters peripubertal mammary gland development in mice. Endocrinology. 2005;146:4138-47.
58. Ayyanan A, Laribi O, Schuepbach-Mallepell S, et al. Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. Mol Endocrinol. 2011;25:1915-23.
59. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Nat Acad Sci USA. 1998;95:5076-81.
60. Markey CM, Luque EH, de Toro Munoz MM, Sonnenschein C, Soto AM. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod. 2001;65:1215-23.
61. Vandenberg LN, Maffini MV, Schaeberle CM, et al. Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice. Reprod Toxicol. 2008;26:210-9.
62. Moral R, Wang R, Russo IH, Lamartiniere CA, Pereira J, Russo J. Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol. 2008;196:101-12.
63. Betancourt AM, Mobley JA, Russo J, Lamartiniere CA. Proteomic analysis in mammary glands of rat offspring exposed in utero to bisphenol A. J Proteomics. 2010;73:1241-53.
64. Bradshaw AD. The role of SPARC in extracellular matrix assembly. J Cell Commun Signal. 2009;3:239-46.
65. Wadia PR, Vandenberg LN, Schaeberle CM, Rubin BS, Sonnenschein C, Soto AM. Perinatal Bisphenol-A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains. Environ Health Perspect. 2007;115:592-8.
66. Singh M, McGinley JN, Thompson HJ. A comparison of the histopathology of premalignant and malignant mammary gland lesions induced in sexually immature rats with those occurring in the human. Lab Invest. 2000;80:221-31.
67. Nandi S, Guzman R, Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Nat Acad Sci USA. 1995;92:3650-7.
68. Murray TJ, Maffini MV, Ucci AA, Sonnenschein C, Soto AM. Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal Bisphenol A exposure. Reprod Toxicol. 2007;23:383-90.
69. Medina D. The preneoplastic phenotype in murine mammary tumorigenesis. J Mammary Gland Biol Neoplasia. 2000;5:393-407.
70. Durando M, Kass L, Piva J, et al. Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect. 2007;115:80-6.
71. Dhimolea E, Maffini MV, Soto AM, Sonnenschein C. The role of collagen reorganization on mammary epithelial morphogenesis in a 3D culture model. Biomaterials. 2010;31:3622-30.
72. Krause S, Jondeau-Cabaton A, Dhimolea E, Soto AM, Sonnenschein C, Maffini MV. Dual regulation of breast tubulogenesis using extracellular matrix composition and stromal cells. Tissue Eng Part A. 2012;18:520-32.
73. Paszek MJ, Weaver VM. The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia. 2004;9:325-42.
74. Rubin BS, Lenkowski JR, Schaeberle CM, Vandenberg LN, Ronsheim PM, Soto AM. Evidence of altered brain sexual differentiation in mice exposed perinatally to low environmentally relevant levels of bisphenol A. Endocrinology. 2006;147:3681-91.
75. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. Perinatal exposure to low doses of bisphenol-A affects body weight, patterns of estrous cyclicity and plasma LH levels. Environ Health Perspect. 2001;109:675-80.
76. Markey CM, Coombs MA, Sonnenschein C, Soto AM. Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs. Evol Dev. 2003;5:1-9.